about
Single nucleotide polymorphisms in the apolipoprotein B and low density lipoprotein receptor genes affect response to antihypertensive treatmentPharmacogenomics and drug response in cardiovascular disordersPharmacogenomics of primary hypertension--the lessons from the past to look toward the future.From pharmacogenetics to personalized medicine: a vital need for educating health professionals and the community.Improving pharmacotherapy outcomes by pharmacogenomics: from expectation to reality?Pharmacogenomics in cardiovascular disease: the role of single nucleotide polymorphisms in improving drug therapy.Chromogranin A polymorphisms are associated with hypertensive renal disease.2007 ESH‐ESC Guidelines for the management of arterial hypertension
P2860
Q24803618-CFFAC593-E2B8-4F84-8A66-D83230565341Q28171051-195150CF-1A78-4547-88C8-62AF826F341FQ35116095-DE0B1B4D-0EFF-4AAC-9F24-212E882C0330Q35814384-A79921B0-214F-4557-BDB5-2C6D87D6EC99Q36278015-E2101AF9-0713-49E3-AE23-DCFF8484D877Q36326202-38299FE5-1457-4D39-8CF7-100DA355C38FQ36667220-C03C7629-01BC-4853-95C1-258A81316320Q56970799-D52A986C-2973-4AEB-87E3-313279E11D38
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Pharmacogenomics of hypertension.
@ast
Pharmacogenomics of hypertension.
@en
type
label
Pharmacogenomics of hypertension.
@ast
Pharmacogenomics of hypertension.
@en
prefLabel
Pharmacogenomics of hypertension.
@ast
Pharmacogenomics of hypertension.
@en
P1476
Pharmacogenomics of hypertension.
@en
P2093
Daniel T O'Connor
Peter E Cadman
P356
10.1097/00041552-200301000-00011
P577
2003-01-01T00:00:00Z